BactiQuant A/S (BACTIQ) Fair Value & Analysis
Industrials · DK · Market cap 87.4M DKK
Fair value as of: Jul 17, 2026
From 3 valuation models · updated 24 days ago
Share price −9.8% over the past month.
Below-average quality, and screening another 81% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (kr 0.6290). The favourable scenario is already priced in.
- Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (kr 0.2635 to kr 0.6290) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.
How to read this chart
60‑month range kr 1.95 – kr 14.02 · fair‑value band kr 0.2635 – kr 0.6290 · the kr 2.30 price screens above the kr 0.4420 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.
Analysis
BactiQuant A/S (BACTIQ) currently trades at kr 2.30, while our model-based Fair Value estimate is kr 0.4420, implying the stock looks roughly 80.8% overvalued today. The Quality Score stands at 37/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 8.3M DKK. Revenue grew 1.4% year over year. The balance sheet holds a net cash position of 9.6M DKK. Fundamentals as of Jul 17, 2026
Our scenario range runs from kr 0.2635 (bear case) to kr 0.6290 (bull case); at kr 2.30, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -81%, BACTIQ screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 3 models by family
Widest divergence: Dividend Discount (kr 0.3900) versus Asset-Based (kr 0.3100). Highest evidence: Gordon GGM (70).
Notify me when BACTIQ reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 26
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
BactiQuant A/S develops, produces, and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company offers Mobile Lab, a handheld tool for pollution tracking; BQ Online 2.0 PRO, an online solution to quantify the bacteria in water systems; and a range of analysis kits to monitor water quality.
Full company description
BactiQuant A/S develops, produces, and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company offers Mobile Lab, a handheld tool for pollution tracking; BQ Online 2.0 PRO, an online solution to quantify the bacteria in water systems; and a range of analysis kits to monitor water quality. It serves various industries in the areas of aquaculture, data centers, oil and gas, water utility, industry, and pharma. The company was founded in 1999 and is based in Horsholm, Denmark.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
BactiQuant A/S reported revenue of kr 8.3M in FY2025 versus kr 8.4M in FY2021, a compound −0.1%/yr. Reported net income was −kr 13.8M in FY2025.
BACTIQ screens 81% overvalued. Compare with Veralto Corporation →
Peer Group
Pollution & Treatment Controls · 91 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Pollution & Treatment Controls median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veralto Corporation VLTO | $94.21 | $69.11 | -27% |
| Zurn Elkay Water Solutions Corporation ZWS | $47.63 | $24.92 | -48% |
| Canmax Technologies Co 300390 | ¥57.02 | ¥10.41 | -82% |
| CECO Environmental Corp CECO | $83.63 | $15.19 | -82% |
| Fujian Longking Co 600388 | ¥17.58 | ¥15.59 | -11% |
| Munters Group MTRS | kr 166.60 | kr 16.90 | -90% |
| China Conch Venture Holdings 0586 | HK$8.83 | HK$14.14 | +60% |
| Mega Union Technology Inc 6944 | 1,005 TWD | 539.58 TWD | -46% |
| MayAir Technology (China) Co 688376 | ¥96.57 | ¥18.80 | -81% |
| Shanghai Emperor of Cleaning Hi-Tech Co 603200 | ¥38.97 | ¥5.73 | -85% |
Compare BactiQuant A/S with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is BactiQuant A/S (BACTIQ) overvalued or undervalued?
What is the fair value of BACTIQ?
What is the quality score of BACTIQ?
What is the revenue of BactiQuant A/S (BACTIQ)?
What is the net profit margin of BACTIQ?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BactiQuant A/S and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.